Will Morton

Molecular Imaging
New analysis supports use of FES-PET in breast cancer patients
F-18 fluoroestradiol (FES)-PET scans can predict whether endocrine therapy could be effective in women with estrogen receptor-positive breast cancer.
March 13, 2025
Fes Pet Abstract Thumbnail
Digital X-Ray
Generative AI model validated in chest x-ray study
A group in South Korea has validated a generative AI model that could reduce reading times and increase chest x-ray reporting accuracy.
March 11, 2025
An example that features an AI-generated report that identified “scattered pulmonary granulomatous calcifications.” In the first session, three of five readers specifically reported the presence of a nodule. Following the introduction of the AI-generated report, only one reader maintained the specific mention of a nodule, whereas the other four readers adapted their reports to include the AI-suggested terminology of “granulomatous calcifications.” AP = anterior-posterior. Image and caption courtesy of RSNA.
Interventional
New embolization agents safe for treating painful joint disorders
Three rapidly biodegradable agents used in embolization procedures appear safe and effective for reducing pain in patients with joint disorders.
March 10, 2025
Knee
Radiation Oncology/Therapy
Consolidation reigns in radiation oncology
Solo practices in radiation oncology dropped significantly between 2015 and 2023 while the number of large practices increased by more than half.
March 7, 2025
Trends
Molecular Imaging
Hormone therapy linked to tau accumulation in older women
A PET study reveals that women over the age of 70 who took menopausal hormone therapy more than a decade prior have faster brain tau accumulation.
March 7, 2025
Ad
Molecular Imaging
Ac-225: From nuclear waste to cancer treatment
U.S. Department of Energy (DOE) efforts to dispose of spent nuclear waste left over from the Cold War has turned into a boon for supplies of actinium-225 (Ac-225).
March 5, 2025
Isotopes1
Molecular Imaging
FES-PET shows promise staging patients with low-grade breast cancer
F-18 fluoroestradiol (FES) PET may improve staging of grade 1 or 2 estrogen receptor-positive breast cancer compared with F-18 FDG-PET.
March 4, 2025
Fes Pet2 Thumbnail
Molecular Imaging
FAPI-PET/CT shows promise in gynecological cancers
Fibroblast activation protein inhibitor (FAPI) PET/CT appears superior to FDG-PET/CT for imaging gynecological cancers.
March 3, 2025
Fapi Gyno Cancers Thumbnail
CT
Radiologists help refute ‘pregnant mummy’ claim
Radiologists have weighed in on a reportedly heated dispute in archeology over whether CT scans show that a mummified ancient Egyptian woman was pregnant.
March 3, 2025
Pregnantmummy
Molecular Imaging
ECR: PET/MRI highly effective for detecting prostate cancer
Hybrid PET/MRI scans outperform either technique alone for identifying tumors in high-risk patients with suspected prostate cancer.
February 28, 2025
Prostate Imaging
Previous Page
Page 6 of 51
Next Page
Top Stories
This image depicts comminuted skull fractures sustained in a pedestrian motor vehicle accident. These are difficult to document by a standard autopsy because the individual fragments are displaced during the internal examination and dissection of the head.
CT
Radiology CSI: CT helps medical examiners determine cause of death
Kalpana Kanal, PhD, of the University of Washington Medical Center in Seattle, spoke to AuntMinnie about forensic CT.
Lung Cancer
CT
Radiomics plus DL improve prediction of lung cancer invasiveness
Mammo Reading 400
Womens Imaging
False-negative breast exams on the rise
Globe Digital Screens
Radiology Education
Is it time to put global health in radiology education curricula?
Join Us!
Sponsor Content
Join Us!
More in Home
5-year CTC screening interval is appropriate for colorectal cancer
By Kate Madden Yee
The study's findings add to an ongoing conversation about the use of CTC for colorectal cancer screening.
September 30, 2025
Colorectal Cancer
ASTRO: Daily MRgRT recontouring improves prostate treatment outcomes
By Kate Madden Yee
Daily online adaptive recontouring is associated with clinically meaningful benefit in patient-reported quality of life measures.
September 30, 2025
Astro Sf
ASTRO: Radiation therapy comparable to surgery for early-stage lung cancer
By Will Morton
At 10 years, overall survival was virtually identical between patients treated with radiation therapy versus surgery.
September 30, 2025
Moscone Center
CT use in the ED has more than doubled over a decade
By Kate Madden Yee
The finding could be due to the "evolving role of CT in ED care delivery," researchers noted.
September 30, 2025
Emergency Entrance
ASTRO: Proton therapy shows promise in breast cancer treatment
By Amerigo Allegretto
Proton radiation achieves similar health-related quality of life measures compared to photon radiation in breast cancer patients.
September 30, 2025
Img 2757
Israeli radiologist discusses response to Oct. 7 attacks
By Will Morton
Workflow and staffing changes led to a reduction in CT turnaround times from 54 minutes to 27 minutes after the October 7, 2023 attack.
September 30, 2025
Representative injuries in patients from the mass casualty incident of October 7, 2023. (A) Axial CT scan at the pelvic level in a 34-year-old male patient shows multiple shrapnel fragments in the pelvis, resulting in fractures of the pelvic bones and lumbar vertebrae (not visible on this image). (B) Coronal reconstruction of a head CT scan in a 20-year-old male patient shows penetrating trauma to the left eyeball with a retained bullet in the orbital cavity. (C) Radiograph of a fetus delivered by emergency cesarean section from a critically injured mother shows a left pneumothorax and catheter in place. (D) Radiograph in a 25-year-old female patient shows a comminuted fracture in the tibial metaphysis with fragment displacement and multiple bony fragments in the surrounding soft tissues.
ASTRO: Trial suggests postoperative RT in high-risk bladder cancer
By Liz Carey
Moderate doses of radiation therapy (RT) after bladder removal surgery cut rates of new pelvic cancer, according to researchers.
September 30, 2025
Moscone Center Astro
ASTRO: Lu-177 PNT2002 added to SBRT delays prostate cancer progression
By Will Morton
Two cycles of lutetium-177 PNT2002 before stereotactic body radiation therapy (SBRT) significantly improved progression-free survival.
September 29, 2025
Moscone Center Astro
ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer
By Liz Carey
Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.
September 29, 2025
Moscone Center Astro
NAPT survey results show promise for proton therapy adoption
By Amerigo Allegretto
Proton therapy continues to experience increased clinical use, but barriers to care continue to limit its potential.
September 29, 2025
Survey Form 400
ASTRO: Low-dose RT effective for treating knee osteoarthritis
By Amerigo Allegretto
Research presented at ASTRO 2025 showed the effectiveness of low-dose radiation therapy for treating knee osteoarthritis.
September 29, 2025
Moscone Center Astro
ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer
By Will Morton
Patients with a prostate tumor subtype known as luminal B had meaningful benefits from the addition of apalutamide to secondary radiotherapy.
September 29, 2025
Moscone Center Astro
Previous Page
Page 6 of 179
Next Page